Title |
Second Cancers in Patients with Neuroendocrine Tumors
|
---|---|
Published in |
PLOS ONE, December 2013
|
DOI | 10.1371/journal.pone.0086414 |
Pubmed ID | |
Authors |
Hui-Jen Tsai, Chun-Chieh Wu, Chia-Rung Tsai, Sheng-Fung Lin, Li-Tzong Chen, Jeffrey. S. Chang |
Abstract |
Second cancers have been reported to occur in 10-20% of patients with neuroendocrine tumors (NETs). However, most published studies used data from a single institution or focused only on specific sites of NETs. In addition, most of these studies included second cancers diagnosed concurrently with NETs, making it difficult to assess the temporality and determine the exact incidence of second cancers. In this nationwide population-based study, we used data recorded by the Taiwan Cancer Registry (TCR) to analyze the incidence and distribution of second cancers after the diagnosis of NETs. |
X Demographics
The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
Mexico | 1 | 50% |
United States | 1 | 50% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 50% |
Scientists | 1 | 50% |
Mendeley readers
The data shown below were compiled from readership statistics for 31 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 31 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 6 | 19% |
Student > Bachelor | 4 | 13% |
Student > Ph. D. Student | 2 | 6% |
Student > Doctoral Student | 2 | 6% |
Student > Master | 2 | 6% |
Other | 6 | 19% |
Unknown | 9 | 29% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 13 | 42% |
Biochemistry, Genetics and Molecular Biology | 3 | 10% |
Arts and Humanities | 1 | 3% |
Psychology | 1 | 3% |
Agricultural and Biological Sciences | 1 | 3% |
Other | 0 | 0% |
Unknown | 12 | 39% |